miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-08
DOI
10.1038/s41598-017-18739-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
- (2017) Ingrid Garajová et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis
- (2017) Ganesh M. Shankar et al. JOURNAL OF NEUROSURGERY-SPINE
- MicroRNA expression profiling in canine prostate cancer
- (2017) Masanori KOBAYASHI et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2
- (2017) Jiangtu He et al. ONCOLOGY REPORTS
- Combination of subxiphoid and intercostal uniportal video-assisted thoracoscopic surgery for bilateral lung lesions: report of two cases and review of the literature
- (2017) Linlin Wang et al. POSTGRADUATE MEDICINE
- MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis
- (2017) Dong Cheng et al. Oncotarget
- Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
- (2017) Francesco R. Evola et al. Frontiers in Pharmacology
- Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis
- (2016) Carolina Zandueta et al. JOURNAL OF PATHOLOGY
- Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration
- (2016) Ntube N.O. Ngalame et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma
- (2016) Mio Hirahata et al. Cancer Medicine
- Long non-coding RNAs: emerging players in osteosarcoma
- (2015) Zheng Li et al. TUMOR BIOLOGY
- MicroRNAs and Potential Targets in Osteosarcoma: Review
- (2015) Valerie B. Sampson et al. Frontiers in Pediatrics
- Primary Osteosarcoma of Rib Mimicking Lung Mass with Secondary Aneurysmal Bone Cyst Formation
- (2014) T.M. Anoop et al. Journal of Thoracic Oncology
- FOSL2 Positively Regulates TGF-β1 Signalling in Non-Small Cell Lung Cancer
- (2014) Junfeng Wang et al. PLoS One
- Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1
- (2013) GE YANG et al. ONCOLOGY REPORTS
- Oncostatin M Is a Growth Factor for Ewing Sarcoma
- (2012) Emmanuelle David et al. AMERICAN JOURNAL OF PATHOLOGY
- FOSL2 promotes leptin gene expression in human and mouse adipocytes
- (2012) Christiane D. Wrann et al. JOURNAL OF CLINICAL INVESTIGATION
- RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets
- (2012) O A Kent et al. ONCOGENE
- Selective Genomic Targeting by FRA-2/FOSL2 Transcription Factor
- (2011) Jeff S. Davies et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
- (2011) Bin Xu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical Cancer
- (2011) Georgios Deftereos et al. PLoS One
- Role of anti-oncomirs miR-143 and -145 in human colorectal tumors
- (2010) Y Akao et al. CANCER GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation